Wire Stories
-
945Business as Usual at Hytera�s Intelligent Manufacturing Center Amid COVID-19
Hytera’s intelligent manufacturing center in Shenzhen has enabled it to maintain production despite the disruption caused by the COVID-19 pandemic. The flexibility...
-
793
COMPUTEX 2020 Rescheduled to September
Presenting 5G & communications, smart solutions, gaming, and startups TAIPEI–(BUSINESS WIRE)–#COMPUTEX2020–Unfortunately, the world is affected by severe infectious pneumonia (COVID-19). As of...
-
854
Cloudflare and Alibaba Cloud Collaborate on Expansion of Bandwidth Alliance
Joint customers outside mainland China can have bandwidth fees waived SAN FRANCISCO–(BUSINESS WIRE)–Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company...
-
961
Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
Dynavax is providing CpG 1018, the adjuvant contained in U.S. FDA-approved HEPLISAV-B vaccine, to support the rapid development of Clover’s COVID-19 vaccine...
-
809
Renesas Introduces RX23E-A MCU Starter Kit to Jumpstart Accurate Analog Evaluation for Industrial Automation and Measurement Equipment
New RSSK Enables Analog Characteristics Evaluation at the Nanovolt Level, Accelerating Time to Market for Industrial IoT Sensors TOKYO–(BUSINESS WIRE)–#IIoT–Renesas Electronics Corporation...
-
843
Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset
China-based biotechnology company signs third agreement with pharmaceutical company gaining exclusive global rights to develop and commercialize anti-PD-L1 Antibody Oncology asset has...
-
796
Samsung Bioepis Announces FDA Approval of 420 mg Multi-dose Vial of ONTRUZANT� (trastuzumab-dttb)
●150 mg and 420 mg vial of ONTRUZANT® are now approved INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced that the U.S....
-
896
IASO Biotherapeutics Raises $60 Million in Series B Financing Led by GL Ventures to Advance Cell Therapies for Cancer Care
NANJING, China–(BUSINESS WIRE)–IASO Biotherapeutics (IASO BIO) today announced the completion of $60 million in series B financing led by GL Ventures, which...
-
900
�Razer Announces 2019 Full Year Financial Results
Revenues Reached Record High Of US$820.8M Adjusted Ebitda Breakeven in Second Half of 2019 (Excluding Exited Mobile Handset Business) Continued Breakthrough of...
-
806
Europe & Asia Pacific Kraft Papers Market Outlook & Projections from 2019 to 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)– The “Europe & Asia Pacific Kraft Papers Market Outlook and Projections, 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The...
